Clinical Trials Logo

Clinical Trial Summary

The current study aims to examine the impact of booster sessions of cognitive control training (CCT) on indicators of depression vulnerability. Remitted depressed individuals (RMD) will be randomized over two groups, each receiving 10 sessions of the adaptive Paced Auditory Serial Addition Task, a well-established CCT procedure (Koster et al., 2017; Siegle et al., 2007). During and following completion of the training procedure, functioning will be monitored on a weekly basis over a period of 15 weeks. During this period, one group will be offered booster sessions based on early warning signs for possible recurrence of depression, whilst the other group will not receive booster sessions.


Clinical Trial Description

Cognitive impairments are closely associated with depression and recent studies have found that these cognitive problems can persist following remission of depression. Internet-delivered cognitive control training (CCT), and the adaptive Paced Auditory Serial Addition Task (aPASAT) in particular, has shown to be an effective preventative intervention for remitted depressed individuals (RMD), where beneficial effects have been found for rumination, depressive symptomatology (Hoorelbeke & Koster, 2017), and risk for recurrence of depression (Hoorelbeke et al., 2021). At the same time, prior studies suggest significant heterogeneity in response to CCT, where RMD individuals can show strong fluctuations in functioning in the months following completion of aPASAT training. In line with this, recent findings suggest that, for individuals with high-risk profiles, initial training gains may diminish over time, resulting in recurrence of internalizing symptomatology (Hoorelbeke et al., 2022). As such, there may be merit in the use of CCT booster sessions. Currently, it is unclear whether offering additional CCT sessions when RMD individuals are reporting increased symptomatology (i.e., adding booster sessions based on early warning signs for possible recurrence of depression) can increase the long-term effectiveness of CCT. In this study, two groups of RMD individuals will perform 10 CCT sessions, after which one group will be offered booster sessions (contingent on indicators of functioning). For this purpose, we will rely on 15 weekly mobile assessments, using the PHQ-9 questionnaire. In addition, functioning will be assessed using a more extensive assessment battery at baseline, post-training (2 weeks after baseline) and follow-up (15 weeks after baseline). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05557760
Study type Interventional
Source University Ghent
Contact Ernst Koster, PhD
Phone + 32 9 2646446
Email Ernst.Koster@ugent.be
Status Recruiting
Phase N/A
Start date October 18, 2022
Completion date September 30, 2024

See also
  Status Clinical Trial Phase
Completed NCT03278756 - Online Cognitive Control Training for Remitted Depressed Patients N/A
Withdrawn NCT03548519 - Online Contingent Attention Training (OCAT) N/A
Not yet recruiting NCT05579015 - Predicting Illness Trajectories In Fully Remitted Major Depression Using Concurrent TBS/fNIRS N/A
Active, not recruiting NCT04325529 - Pharmaco-Neuroimaging Studies of Approach/Avoidance Behaviors and Post-Mortem Studies: Study 1.2 (Stress Manipulation)
Completed NCT05166798 - Optimal Dose of a Cognitive Control Training for Depression Vulnerability N/A
Completed NCT02407652 - Cognitive Control Training for Remitted Depressed Patients N/A
Recruiting NCT04864353 - Internet-delivered Intervention Targeting Residual Cognitive Symptoms After Major Depressive Disorder N/A
Terminated NCT04944758 - Feasibility of Adherence to Light Therapy N/A